
Celldex Therapeutics CLDX
€ 21.11
2.22%
Quartalsbericht 2025-Q3
hinzugefügt 10.11.2025
Celldex Therapeutics DPO 2011-2026 | CLDX
DPO Jährlich Celldex Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.17 K | 4.16 K | 8.34 K | 4.15 K | 2.03 K | - | - | - | - | - | - | 351 | 25.2 | 37.4 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 8.34 K | 25.2 | 3.16 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Harmony Biosciences Holdings
HRMY
|
28.9 | $ 27.99 | 4.17 % | $ 1.59 B | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.81 | 1.31 % | $ 4.42 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Axsome Therapeutics
AXSM
|
529 | $ 167.61 | -4.09 % | $ 8.34 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
65 | $ 194.87 | -0.75 % | $ 28.5 B | ||
|
BioMarin Pharmaceutical
BMRN
|
245 | $ 63.02 | 0.15 % | $ 12 B | ||
|
Baudax Bio
BXRX
|
140 | - | 0.59 % | $ 63 K | ||
|
Amneal Pharmaceuticals
AMRX
|
21.1 | $ 14.72 | 2.08 % | $ 4.55 B | ||
|
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B |